Market Cap

BML, Inc. Market Capitalization:

¥143.56 Billion

JPY as of Jan. 1, 2026

US$916.1 Million

business BML, Inc. Company Profile

BML, Inc. Main Stock Listing

JPX: 4694

Market Capitalization History of BML, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $222.61 B
Danaher $164.98 B
Siemens Healthineers AG $57.84 B
IDEXX Laboratories, Inc. $53.62 B
Lonza Group Ltd $47.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of BML, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 ¥143.56 B 25.26%
Jan. 1, 2025 ¥114.61 B 0.74%
Jan. 1, 2024 ¥113.77 B -7.04%
Jan. 1, 2023 ¥122.38 B -9.35%
Jan. 1, 2022 ¥135.00 B -4.79%
Jan. 1, 2021 ¥141.80 B 16.61%
Jan. 1, 2020 ¥121.60 B 4.33%
Jan. 1, 2019 ¥116.55 B 1.90%
Jan. 1, 2018 ¥114.38 B 8.24%
Jan. 1, 2017 ¥105.67 B 48.43%
Jan. 1, 2016 ¥71.19 B 16.16%
Jan. 1, 2015 ¥61.29 B -9.47%
Jan. 1, 2014 ¥67.70 B 56.35%
Jan. 1, 2013 ¥43.30 B 23.63%
Jan. 1, 2012 ¥35.02 B -18.38%
Jan. 1, 2011 ¥42.91 B -8.00%
Jan. 1, 2010 ¥46.64 B 15.16%
Jan. 1, 2009 ¥40.50 B 22.65%
Jan. 1, 2008 ¥33.02 B -29.46%
Jan. 1, 2007 ¥46.81 B 19.90%
Jan. 1, 2006 ¥39.04 B 30.86%
Jan. 1, 2005 ¥29.84 B -2.54%
Jan. 1, 2004 ¥30.61 B -8.53%
Jan. 1, 2003 ¥33.47 B -39.54%
Jan. 1, 2002 ¥55.36 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

BML, Inc. Categories

Japan languages Healthcare languages Diagnostics & Research
Japan Healthcare Japan Diagnostics & Research

Stocks & Indices

BML, Inc. has the following listings and related stock indices.


Stock: JPX: 4694

Stock: Munich: BMZ

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.